| |
 |
|
Class Information
Number: 424/188.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Retroviridae (e.g., feline leukemia, etc.) > Immunodeficiency virus (e.g., hiv, etc.)
Description: Subject matter wherein the virus is one that is associated with an immunodeficiency syndrome such as AIDS in humans or an AIDS-related syndrome in animals.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 8435535 |
Fusion proteins of HIV regulatory/accessory proteins |
May. 7, 2013 |
| 8431530 |
Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
Apr. 30, 2013 |
| 8415399 |
Retrovirus-infection inhibitor |
Apr. 9, 2013 |
| 8377477 |
Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
Feb. 19, 2013 |
| 8372407 |
Chimeric HIV fusion proteins as vaccines |
Feb. 12, 2013 |
| 8367068 |
Use of triplex structure DNA in transferring nucleotide sequences |
Feb. 5, 2013 |
| 8354247 |
Glycoprotein synthesis and remodeling by enzymatic transglycosylation |
Jan. 15, 2013 |
| 8323961 |
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV |
Dec. 4, 2012 |
| 8293247 |
Modified influenza virus for monitoring and improving vaccine efficiency |
Oct. 23, 2012 |
| 8268323 |
Conformationally stabilized HIV envelope immunogens |
Sep. 18, 2012 |
| 8236324 |
Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens |
Aug. 7, 2012 |
| 8216585 |
Targeted particles and methods of using the same |
Jul. 10, 2012 |
| 8197820 |
HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination |
Jun. 12, 2012 |
| 8197819 |
Env polypeptide complexes and methods of use |
Jun. 12, 2012 |
| 8197821 |
Human immunodeficiency virus integrase--Transportin--SR protein--protein interactions |
Jun. 12, 2012 |
| 8183352 |
Attenuated vif DNA immunization cassettes for genetic vaccines |
May. 22, 2012 |
| 8147840 |
Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid |
Apr. 3, 2012 |
| 8147839 |
Fusion proteins of HIV regulatory/accessory proteins |
Apr. 3, 2012 |
| 8137931 |
Fusion proteins of HIV regulatory/accessory proteins |
Mar. 20, 2012 |
| 8133494 |
Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2 |
Mar. 13, 2012 |
| 8119144 |
HIV-1 Clade A consensus sequences, antigens, and transgenes |
Feb. 21, 2012 |
| 8119140 |
Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins |
Feb. 21, 2012 |
| 8093046 |
CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions |
Jan. 10, 2012 |
| 8092805 |
Dual inhibitors of HIV-1 gp-120 interactions |
Jan. 10, 2012 |
| 8080369 |
Methods for activating peripheral blood mononuclear cells (PBMCs) by administering human immunodeficiency virus (HIV) Tat under physiological oxygen levels |
Dec. 20, 2011 |
| 8076060 |
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma |
Dec. 13, 2011 |
| 8057798 |
Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells |
Nov. 15, 2011 |
| 8044185 |
Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes |
Oct. 25, 2011 |
| 8034350 |
Methylated tat polypeptides and methods of use thereof |
Oct. 11, 2011 |
| 8029797 |
Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regions |
Oct. 4, 2011 |
| 8017126 |
Modified HIV-1 envelope proteins |
Sep. 13, 2011 |
| 7993651 |
Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopes |
Aug. 9, 2011 |
| 7988974 |
Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier |
Aug. 2, 2011 |
| 7988975 |
Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies |
Aug. 2, 2011 |
| 7981430 |
Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome |
Jul. 19, 2011 |
| 7972603 |
Stable immunogenic product comprising antigenic heterocomplexes |
Jul. 5, 2011 |
| 7951377 |
Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens |
May. 31, 2011 |
| 7947822 |
HIV vaccines based on Env of multiple clades of HIV |
May. 24, 2011 |
| 7943140 |
Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1 |
May. 17, 2011 |
| 7943139 |
Methods of generating a humoral immune response against human immunodeficiency virus (HIV) comprising administering Nef apoptotic motif-containing polypeptide-conjugates |
May. 17, 2011 |
| 7939083 |
Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain |
May. 10, 2011 |
| 7919100 |
Soluble and stabilized trimeric form of gp41 polypeptides |
Apr. 5, 2011 |
| 7919101 |
Highly potent synergistic combinations of human immunodeficiency virus (HIV) fusion inhibitors |
Apr. 5, 2011 |
| 7910716 |
Nucleic acids encoding modified South African HIV-1 subtype C gag proteins |
Mar. 22, 2011 |
| 7901690 |
Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods |
Mar. 8, 2011 |
| 7888003 |
Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein |
Feb. 15, 2011 |
| 7847085 |
Recombinant HIV-1 gp120 immunogen with three different V3 loops from viruses of different clades |
Dec. 7, 2010 |
| 7838001 |
Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses |
Nov. 23, 2010 |
| 7838275 |
Anti-HIV and anti-tumor peptides and fragments of lysozyme |
Nov. 23, 2010 |
| 7815916 |
Cloning and expression of HTLV-III DNA |
Oct. 19, 2010 |
|
|
|
